FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072982 [Registered on: 27/08/2024] Trial Registered Prospectively
Last Modified On: 05/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Presepsin: Evaluation of a Novel marker for early diagnosis of Sepsis 
Scientific Title of Study   Evaluation of Diagnostic Accuracy of Novel biomarker Presepsin compared to Procalcitonin in patients with Suspected Sepsis coming to Emergency Department 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  John Benny 
Designation  Junior Resident 
Affiliation  JSS Medical College and Hospital,JSS AHER 
Address  Department of Emergency Medicine,JSS Hospital,Agrahara,Mysuru Mysore

Mysore
KARNATAKA
570004
India 
Phone  830103025  
Fax    
Email  johnbenny0023@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Brinda Basavaraju 
Designation  Professor and Head of Department 
Affiliation  JSS Medical College and Hospital,JSS AHER 
Address  Department of Emergency Medicine,JSS Hospital,Agrahara,Mysuru Mysore

Mysore
KARNATAKA
570004
India 
Phone  9844327471  
Fax    
Email  brindabasavaraju@jssuni.edu.in  
 
Details of Contact Person
Public Query
 
Name  Madhu Srinivasarangan 
Designation  Associate Professor 
Affiliation  JSS Medical College and Hospital,JSS AHER 
Address  Department of Emergency Medicine,JSS Hospital,Agrahara,Mysuru Mysore

Mysore
KARNATAKA
570004
India 
Phone  9449813976  
Fax    
Email  madhu@jssuni.edu.in  
 
Source of Monetary or Material Support  
JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysore, Karnataka,India,570004 
 
Primary Sponsor  
Name  John Benny 
Address  Department of Emergency Medicine,JSS Medical College and Hospital, Agrahara Circle, Mysuru, Karnataka, India,570004 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr John Benny  JSS Hospital,Mysuru  Department of Emergency Medicine ,JSS Hospital, Agrahara Circle,Mysore,Karnataka,India,570004
Mysore
KARNATAKA 
8301030625

johnbenny0023@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, JSS Medical College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: A419||Sepsis, unspecified organism,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Patients above 18 years with suspected sepsis presenting to Emergency Medicine Department based on
1. Clinicians suspicion of sepsis
2. A known focus of sepsis
3. Signs and symptoms suggestive of sepsis
4. High risk of sepsis 
 
ExclusionCriteria 
Details  1. Immuno-compromised
2. Malignancy 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Primary : Evaluation of accuracy of the Novel biomarker Presepsin in detecting sepsis among patients presenting to the Emergency Department with features suggestive of sepsis using Blood Culture results as standard.   Blood sample for Presepsin levels will be collected at admission and compared against Blood Culture report which will be available at 48 hours. 
 
Secondary Outcome  
Outcome  TimePoints 
Comparison of the efficacy of Presepsin & Procalcitonin in detecting suspected sepsis among patients presenting to Emergency Department with features suggestive of sepsis  Blood samples for Presepsin & Procalcitonin levels will be collected at admission & compared against each other & with the Blood Culture report which will be available at 48 hours 
 
Target Sample Size   Total Sample Size="92"
Sample Size from India="92" 
Final Enrollment numbers achieved (Total)= "92"
Final Enrollment numbers achieved (India)="92" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/09/2024 
Date of Study Completion (India) 30/06/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
Materials and Methods:
a) Study Design : A Cross Sectional Comparative Observational Study in which different blood samples will be tested.

b) Study Duration : 18 months
c) Sampling technique: Purposive Sampling
     
   Sample size is estimated considering prevalence of sepsis patient presenting to Emergency is taken as 6.4%(ref).Sample size when calculated comes to 92.

     In patients presenting to Emergency Department with suspected sepsis; blood samples are drawn for blood culture and sensitivity and serum procalcitonin levels routinely. Along with these, blood samples will be drawn for Presepsin testing. After 48 hours blood culture reports will be collected ,along with Procalcitonin and Presepsin levels .These values will be compared with blood culture reports.

d) Study Population and source of data
           Patients presenting above 18 years with suspected sepsis presenting to Emergency Department based on
      1)  Clinician’s suspicion of sepsis
      2) A known sepsis
      3) Signs and symptoms suggestive of sepsis
      4) High risk of infection


e) Subject Eligibility
       1) Inclusion Criteria
            -   Age> 18 years
            -  Patients with suspected sepsis presenting to Emergency Department based on 
                  *  Clinician’s suspicion of sepsis
                  * A known focus of sepsis
                  * Signs and symptoms suggestive of sepsis
                  * High risk of sepsis
      2) Exclusion Criteria
                  * Immunocompromised 
                  * Malignancy

f) Study Assessment of end points
                 Patients will be tracked to record reports of Presepsin ,Procalcitonin and after 48 hours blood culture report.

g) Study Conduct
      
        The study will be conducted in the Emergency Department of JSS Hospital, Mysuru in patients aged above 18 years presenting with suspected sepsis to Emergency Department.
  
      1)  Data of patients admitted at Emergency Department of JSS hospital fulfilling and exclusion criteria will be collected
      2) Patients with sepsis will be selected based on clinician’s suspicion of sepsis. Blood samples will be collected from patients and will be sent to Microbiology lab.
      3) Samples will be stored at Microbiology lab and then will be analyzed by ELISA with respective biomarker kits.

h) Instruments required : Presepsin and Procalcitonin test kits


i) Informed Consent: English and Kannada forms are included 

j)  Investigational Product Management
             
                  Presepsin test kit will be collected and stored in Microbiology Laboratory in JSS Hospital, Mysuru. It will be stored at 2-8o C. .Presepsin samples will be collected and stored Test will be run in batches whenever sufficient samples are available. The Primary Investigator will bear all the cost of the Biomarker and the burden will not fall on the patient.

k) Summary statistics will be done by means of proportions for categorical/binary variables and mean, median, standard deviation , Inter Quartile Range (IQR) for continuous variables. Inferential statistics will be done by using independent t test ,chi square test, ROC curve with AUC, sensitivity , specificity, PPV, NPV with 95% CI and binary logistic regression. All the statistical methods will be done using SPSS 28.0 version of windows . P < 0.05 will be considered statistically significant.
 

               



 
Close